EW Healthcare Partners (EW) has acquired a majority stake in Laboratoires Majorelle (Majorelle) from its Founders to support its growth and European expansion in line with the Founders strategy.
Headquartered in Paris, Majorelle is a French specialty pharma company focused on prescription and OTC products in womens health and urology that offer health solutions for men and women in France. The companys portfolio of products commands a strong position in the French market with its highly respected brand image and affordable pricing.
Since its founding in 2012, Majorelle has developed the most relevant and dynamic womens health product range in the French market, meeting unmet medical needs, making new treatments available to patients, and offering significant public health outcomes. The company has 65 employees and has experienced over 20 per cent annual revenue and EBITDA growth in recent years.
Upon completion of the transaction, the Founders will retain a minority stake in the company and will work closely together with EW to drive continued rapid revenue and EBITDA growth.
Mehdi el Glaoui, Founder of Majorelle, says: We are enthusiastic about partnering with EW Healthcare Partners in our continued growth. We are proud of having built a unique fully-fledged specialty pharmaceutical company in less than a decade thanks to a highly talented team. Our team up with EW is a powerful combination to seize the many growth opportunities we see ahead of us and achieve our ambitions in France and international markets.